Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

10.12
Delayed Data
As of Mar 24
 +0.13 / +1.30%
Today’s Change
4.09
Today|||52-Week Range
11.40
+39.39%
Year-to-Date
Corcept Therapeutices Eyes Another Double
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close9.99
Today’s open9.98
Day’s range9.88 - 10.25
Volume597,845
Average volume (3 months)804,431
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+235.71%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+61.72%
P/E ratio144.6
Price/Sales9.87
Price/Book27.21

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.04+0.18%
XNCRXencor Inc+0.82+3.46%
EBSEmergent BioSolution...+0.46+1.62%
LOXOLoxo Oncology Inc+1.01+2.27%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$81.3M
Annual profit (last year)$8.1M
Net profit margin10.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs